References
- Bess EN, Bisanz JE, Yarza F, Bustion A, Rich BE, Li X, Kitamura S, Waligurski E, Ang QY, Alba DL. Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria. Nat Microbiol. 2020 Jan;5(1):56–66. https://doi.org/10.1038/s41564-019-0596-1
- Buttimer C, Bottacini F, Shkoporov AN, Draper LA, Ross P, Hill C. Selective isolation of Eggerthella lenta from human faeces and characterisation of the species prophage diversity. Microorganisms. 2022 Jan 17;10(1):195. https://doi.org/10.3390/microorganisms10010195
- CLSI. Performance standards for antimicrobial susceptibility testing. 29th ed. CLSI supplement M100. Wayne (USA): Clinical and Laboratory Standards Institute; 2019.
- Deng H, Yang S, Zhang Y, Qian K, Zhang Z, Liu Y, Wang Y, Bai Y, Fan H, Zhao X, et al. Bacteroides fragilis prevents Clostridium difficile infection in a mouse model by restoring gut barrier and microbiome regulation. Front Microbiol. 2018 Dec 21;9:2976. https://doi.org/10.3389/fmicb.2018.02976
- Fatima T, Hasan R, Tariq S. Eggerthella lenta bacteraemia in endometrial adenocarcinoma – a case report from Pakistan. Pak Med Assoc. 2020 Jun;70(6):1079–1080. https://doi.org/10.5455/JPMA.285088
- Gardiner BJ, Tai AY, Kotsanas D, Francis MJ, Roberts SA, Ballard SA, Junckerstorff RK, Korman TM. Clinical and microbiological characteristics of Eggerthella lenta bacteremia. J Clin Microbiol. 2015 Feb;53(2):626–635. https://doi.org/10.1128/JCM.02926-14
- Haiser HJ, Seim KL, Balskus EP, Turnbaugh PJ. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes. 2014 Mar-Apr;5(2):233–238. https://doi.org/10.4161/gmic.27915
- Kageyama A, Benno Y, Nakase T. Phylogenetic evidence for the transfer of Eubacterium lentum to the genus Eggerthella as Eggerthella lenta gen. nov., comb. nov. Int J Syst Bacteriol. 1999 Oct; 49(4): 1725–1732. https://doi.org/10.1099/00207713-49-4-1725
- Kumar K, Jaiswal SK, Dhoke GV, Srivastava GN, Sharma AK, Sharma VK. Mechanistic and structural insight into promiscuity based metabolism of cardiac drug digoxin by gut microbial enzyme. J Cell Biochem. 2018 Jul;119(7):5287–5296. https://doi.org/10.1002/jcb.26638
- Lee HJ, Hong SK, Choi WS, Kim EC. The first case of Eggerthella lenta bacteremia in Korea. Ann Lab Med. 2014 Mar;34(2):177–179. https://doi.org/10.3343/alm.2014.34.2.177
- Liderot K, Ratcliffe P, Lüthje P, Thidholm E, Özenci V. Microbiological diagnosis of Eggerthella lenta blood culture isolates in a Swedish tertiary hospital: Rapid identification and antimicrobial susceptibility profile. Anaerobe. 2016 Apr;38:21–24. https://doi.org/10.1016/j.anaerobe.2015.11.005
- Saunders E, Pukall R, Abt B, Lapidus A, Glavina Del Rio T, Copeland A, Tice H, Cheng JF, Lucas S, Chen F, et al. Complete genome sequence of Eggerthella lenta type strain (VPI 0255T). Stand Genomic Sci. 2009 Sep 28;1(2):174–182. https://doi.org/10.4056/sigs.33592
- Silva-García O, Valdez-Alarcón JJ, Baizabal-Aguirre VM. Wnt/ β-catenin signaling as a molecular target by pathogenic bacteria. Front Immunol. 2019 Sep 27;10:2135. https://doi.org/10.3389/fimmu.2019.02135
- Stinear TP, Olden DC, Johnson PD, Davies JK, Grayson ML. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet. 2001 Mar 17;357(9259):855–856. https://doi.org/10.1016/S0140-6736(00)04206-9
- Ugarte-Torres A, Gillrie MR, Griener TP, Church DL. Eggerthella lenta bloodstream infections are associated with increased mortality following empiric piperacillin-tazobactam (TZP) monotherapy: A population-based cohort study. Clin Infect Dis. 2018 Jul 2; 67(2): 221–228. https://doi.org/10.1093/cid/ciy057
- Venugopal AA, Szpunar S, Johnson LB. Risk and prognostic factors among patients with bacteremia due to Eggerthella lenta. Anaerobe. 2012 Aug;18(4):475–478. https://doi.org/10.1016/j.anaerobe.2012.05.005
- Wade WG, Downes J, Dymock D, Hiom SJ, Weightman AJ, Dewhirst FE, Paster BJ, Tzellas N, Coleman B. The family Coriobacteriaceae: reclassification of Eubacterium exiguum (Poco et al. 1996) and Peptostreptococcus heliotrinreducens (Lanigan 1976) as Slackia exigua gen. nov., comb. nov. and Slackia heliotrinireducens gen. nov., comb. nov., and Eubacterium lentum (Prevot 1938) as Eggerthella lenta gen. nov., comb. nov. Int J Syst Bacteriol. 1999 Apr; 49(2): 595–600. https://doi.org/10.1099/00207713-49-2-595
- Woerther PL, Antoun S, Chachaty E, Merad M. Eggerthella lenta bacteremia in solid tumor cancer patients: Pathogen or witness of frailty? Anaerobe. 2017 Oct;47:70–72. https://doi.org/10.1016/j.anaerobe.2017.04.010